All relevant data are within the paper and its Supporting Information files.

Background {#sec005}
==========

Non-communicable chronic conditions and disabilities that manifest in later life are heavily influenced by physical and social exposures, including behaviours, across the life course \[[@pone.0144405.ref001],[@pone.0144405.ref002]\], leading to an accumulation of risks in older age. The four main behavioural risk factors (smoking, excessive consumption of alcohol, poor diet and low levels of physical activity) have been estimated to contribute to close to half of the burden of illness in developed countries \[[@pone.0144405.ref003],[@pone.0144405.ref004]\] and are known to be unequally distributed in the population particularly affecting the most vulnerable in society \[[@pone.0144405.ref005]\]. Importantly there is a contingent and temporal nature of these behavioural exposures in mid-life \[[@pone.0144405.ref006]--[@pone.0144405.ref008]\] and epidemiological data suggests that it ought to be possible to prevent or delay morbidity and mortality \[[@pone.0144405.ref009]\] whilst promoting successful aging and quality of life \[[@pone.0144405.ref010]--[@pone.0144405.ref012]\], if adoption of healthy behaviours is encouraged across life course and society.

Although many systematic reviews have looked at the links between individual behavioural risk factors and health outcomes \[[@pone.0144405.ref013]--[@pone.0144405.ref019]\], a comprehensive overview across behavioural risk factors and outcomes has yet to be undertaken. There remain uncertainties regarding associations between the relative contributions of behavioural and lifestyle factors, in mid-life specifically, to prevalence, risk and outcomes of non-communicable chronic conditions (for example, dementia, cancer and cardiovascular diseases), disabilities and frailty (including quality of life, and mortality). That is particularly true for the relationship between behavioural risk factors and frailty, where the operational definition of this complex syndrome is still controversial \[[@pone.0144405.ref020],[@pone.0144405.ref021]\]; and for dementia where the aetiology and natural history of disease is still uncertain \[[@pone.0144405.ref022],[@pone.0144405.ref023]\].

This systematic review was one of a series of reviews conducted to inform the development of UK national public health guidance on mid-life approaches to prevent dementia, disability and frailty in later life \[[@pone.0144405.ref024]\]. The aim of the review was to assess the behavioural risk factors in mid-life that are associated with successful ageing and the primary prevention or delay of disability, dementia, frailty (DDF) and non-communicable chronic conditions. The goal was not to summarise the whole of the epidemiological evidence on behavioural risk in adult life. Rather, we aimed to identify associations specifically derived from people in mid-life to inform the development of well-targeted interventions that will minimise the impact of ill health in later life. With a similar focus, the other two reviews in the series looked at the effectiveness of mid-life interventions on behavioural risks and late life outcomes, and at key issues for people in mid-life that prevent or limit, or which help or motivate them to take up and maintain healthy behaviours.

Methods {#sec006}
=======

The review was conducted as a rapid systematic review to provide best available evidence within limited timescales. The scope of the review was defined by the funders (National Institute for Health and Care Excellence---NICE), after open consultation with stakeholders and the protocol ([S1 Text](#pone.0144405.s006){ref-type="supplementary-material"}) was agreed prior to the start of work. Established systematic review methods of NICE (NICE 2015) were broadly followed, except as described below.

Searches {#sec007}
--------

The following electronic sources were searched for peer-reviewed studies published in the English language since the year 2000: MEDLINE, EMBASE, PsycINFO, CINAHL, Health Management Information Consortium, Social Science Citation Index, the HTA database, Cochrane Database of Systematic Reviews, and Cochrane Database of Abstracts of Reviews of Effectiveness as well as relevant websites ([S2 Text](#pone.0144405.s007){ref-type="supplementary-material"}).

Primary longitudinal cohort studies were identified using an observational study search filter \[[@pone.0144405.ref025]\]. To enable a manageable number of search hits, the searches were limited to studies in which terms related to mid-life/middle-aged were indexed in the title/abstract or MeSH term. Time constraints precluded hand searches or contact of authors for additional data.

Inclusion and exclusion criteria {#sec008}
--------------------------------

### Populations {#sec009}

The populations covered by this review included 1) mid-life adults (aged 40--64 years), 2) adults aged 39 and younger in populations at higher risk of health inequalities, which refer to people from disadvantaged and minority groups. For this review 'disadvantaged and minority groups' includes (but is not limited to) people of low socioeconomic status; ethnic minority groups; LGBT community groups; travellers; and other groups with protected characteristics under the equality and diversity legislation.

Studies in populations with mid-life dementia or pre-existing cognitive impairment, and non-communicable chronic conditions were excluded, as were studies of specific disabilities associated with modifiable behavioural risk factors

### Exposure {#sec010}

Behavioural risk factors in the populations described above include (but are not limited to): physical activity; diet and nutrition; smoking; alcohol consumption; and social activity. Studies that reported mid-life weight change/cycling (as a health behaviour) were included whereas studies focusing on mid-life obesity (as a risk factor) were excluded.

### Outcomes {#sec011}

Outcomes included (but were not limited to): dementia, disability (i.e. activities of daily living (ADL), instrumental activities of daily living (IADL), independence, mobility), frailty, quality of life, cardiovascular diseases and stroke, renal disease, cancer, chronic obstructive pulmonary disease, type 2 diabetes, osteoporosis and bone health, mental health.

### Study design {#sec012}

Primary longitudinal cohort studies that reported multivariate analyses and provided information on the association between behavioural risk factors at mid-life and health or ageing outcomes in later life (\>/ = 5 years follow-up) as listed above were eligible for inclusion. Cross-sectional and univariate analyses were excluded. Abstracts, letters and editorials were also excluded.

### Identification of relevant studies {#sec013}

Titles, abstracts and papers were screened for inclusion by two reviewers. Differences between reviewers' results were resolved by discussion and when necessary in consultation with a third reviewer. [Fig 1](#pone.0144405.g001){ref-type="fig"} illustrates the flow chart for the study selection process. Studies excluded at the full paper screening stage are listed in [S1 Table](#pone.0144405.s001){ref-type="supplementary-material"} along with the reason for exclusion.

![Search Results for Primary Studies.](pone.0144405.g001){#pone.0144405.g001}

Quality Assessment {#sec014}
------------------

Quality appraisal of cohort studies was done using a validated quality appraisal checklist \[[@pone.0144405.ref024]\]. Each full paper was assessed by one reviewer and checked for accuracy by another. A minimum of 10% of the studies was assessed twice and discrepancies resolved by discussion. No studies were excluded on the basis of quality.

Data extraction and evidence synthesis {#sec015}
--------------------------------------

Data was extracted on study detail, population and setting, study design, outcomes and method of analysis, and results. To ensure accurate reporting, the data extraction pro-forma was piloted against a selection of papers. A full summary of studies, exposures, outcomes and details of effect sizes are reported in [Table 1](#pone.0144405.t001){ref-type="table"}.

10.1371/journal.pone.0144405.t001

###### Overview of Included Studies.

![](pone.0144405.t001){#pone.0144405.t001g}

  Study                                                       Country                               n                                                                             Age at baseline                                 Length of follow-up                                                                   Quality
  ----------------------------------------------------------- ------------------------------------- ----------------------------------------------------------------------------- ----------------------------------------------- ------------------------------------------------------------------------------------- ---------
  **Physical Activity (PA)**                                                                                                                                                                                                                                                                                            
  Andel 2008 (Case control study)                             Sweden                                264 dementia 2870 controls (90 twin pairs)                                    Mean 48.1 (SD 4.9)                              31.4 years                                                                            \+
  Britton 2008                                                UK (England)                          5823                                                                          35--55                                          17 years                                                                              \+
  Carlson 2008                                                US                                    147 twin pairs                                                                45 (SD 3)                                       20--40 years                                                                          ++
  Chang 2010                                                  Iceland                               4761                                                                          51                                              26 years                                                                              \-
  Chang 2013 (Same study as Chang 2010, different outcomes)   Iceland                               4753                                                                          51 (SD 7)                                       25 years                                                                              \-
  Debette 2011                                                USA                                   1352                                                                          61±9                                            10yrs                                                                                 \+
  Ekelund 2005                                                UK (England)                          605                                                                           53 (mean)                                       5.6 years                                                                             \+
  Elwood 2013 (Caerphilly cohort study)                       UK (Wales)                            2235                                                                          45--59                                          30 years                                                                              ++
  Englund 2011 (Case-control study)                           Sweden                                81 cases/ 156 controls                                                        57 (SD 5)                                       11 years                                                                              \-
  Englund 2013 (Case-control study)                           Sweden                                376 cases/402 controls                                                        54 (SD 6)                                       11 years                                                                              \-
  Friedland 2001 (Case-control study)                         US                                    193 cases/358 controls (for total study, not reported for 40--59 year olds)   40--59                                          \>12 (not fully reported)                                                             \-
  Harmsen 2006                                                Sweden                                6193                                                                          47--55                                          28 years                                                                              \+
  Hamer 2013                                                  UK (England)                          3454                                                                          63.7 (SD 8.9)                                   8 years                                                                               ++
  Holtermann 2009                                             Denmark                               4952                                                                          40--59                                          30 years                                                                              \+
  Holme 2007 (Oslo study)                                     Norway                                6382                                                                          40--49                                          28 years                                                                              \-
  Hu 2003                                                     Finland                               13290                                                                         35--64                                          12 years                                                                              \+
  Hu 2004                                                     Finland                               18892                                                                         25--74 (mean age 42--48)                        9.8 years                                                                             \+
  Hu 2005                                                     Finland                               47212                                                                         25--64 (mean age 41--46)                        17.7 years                                                                            \+
  Hu 2007                                                     Finland                                                                                                             25--64 (mean age 42--49)                        18.9 years                                                                            \+
  Knopman 2001                                                USA                                   10,963                                                                        47--70                                          6yrs                                                                                  \+
  Lahti 2010                                                  Finland                               5437 women, 1257 men                                                          49--51                                          5--7 years                                                                            \+
  Lang 2007                                                   UK \[England (ELSA study), and US\]   8702 (US)& 1507 (UK) (from 2 studies                                          50--69 (mean 60.2 & 58)                         6 years                                                                               \+
  Malmberg 2006                                               Finland                               1791                                                                          40--64                                          16 years                                                                              \+
  Meisinger 2007                                              Germany                               3501 men, 3475 women                                                          45--74                                          8.6 years                                                                             \+
  Menotti 2006                                                Italy                                 1712                                                                          40--49                                          5 years                                                                               \+
  Morgan 2012 (Caerphilly cohort study)                       UK (Wales)                            1005                                                                          45--59                                          16 years                                                                              \+
  Nokes 2012                                                  US                                    244                                                                           35--45                                          6 years                                                                               \+
  Ostbye 2002                                                 US                                    7845 (HRS study) 5037                                                         51--61                                          5--6 yrs                                                                              \-
  Patel 2006                                                  Italy                                 1001                                                                          40--60                                          7 years                                                                               \+
  Pitsavos 2004                                               Greece (Corfu)                        529                                                                           49 ±6                                           40 years                                                                              \+
  Riserus 2007                                                Sweden                                770                                                                           50                                              20 yrs (70--73 to 91--95)                                                             \+
  Rovio 2005                                                  Sweden                                2000                                                                          50                                              21 years                                                                              \+
  Rovio 2007 (Same study as Rovio 2005)                       Sweden                                1449                                                                          50                                              21 years                                                                              \+
  Sabia 2009                                                  England                               5123                                                                          44 (mean)                                       17 years (85--88 to 02--04)                                                           \+
  Stevens 2009                                                England and Scotland                  1.29 million women                                                            50--64 (mean 56)                                96--01 to 05--07 Mean yrs of follow-up: 7.2 for cancer incidence; 8.9 for mortality   \+
  Sun 2010                                                    US                                    13535                                                                         60 (mean age)                                   14 years                                                                              ++
  Szoeke 2006                                                 US                                    224                                                                           50 (mean)                                       11 years                                                                              \+
  Wannamethee 2001                                            UK (England)                          7630                                                                          40--59                                          18.8 years                                                                            \+
  Wiles 2007 (Caerphilly cohort study)                        UK (Wales)                            2512                                                                          45--59                                          10 years                                                                              ++
  Xu 2010                                                     South East Queensland, Australia      564                                                                           45--60 yrs (mean 55)                            2001--06                                                                              **-**
  Yu 2003 (Caerphilly cohort study)                           UK (Wales)                            1975                                                                          45--59                                          10.5 years                                                                            \+
  **Physical Inactivity**                                                                                                                                                                                                                                                                                               
  Christensen 2006                                            Denmark                               376                                                                           50, 60, 70                                      25 years                                                                              \-
  Haapanen-Niemi 2000                                         Finland                               2212 (295 PA)                                                                 35--63                                          16 years                                                                              \+
  **Diet**                                                                                                                                                                                                                                                                                                              
  Akbaraly 2013                                               UK                                    8815                                                                          35--55 years                                    18 years                                                                              \+
  Britton 2008                                                UK                                    5823                                                                          35--55 years (mean: 44)                         20 years                                                                              \+
  Elwood 2013                                                 UK (Caerphilly)                       2235                                                                          45--59 years                                    30 years                                                                              \+
  Eskelinen 2008                                              Finland                               1449                                                                          SD: 50.2                                        21 years                                                                              \+
  Eskelinen 2009 (CAIDE study)                                Finland                               1409                                                                          SD: 50.4                                        21 years                                                                              \+
  He 2004                                                     United States                         74063                                                                         38--63 years                                    12 years                                                                              \+
  Hodge 2013                                                  Australia                             8660                                                                          50--69 years                                    12 years                                                                              \+
  Hughes 2010                                                 Sweden                                3779 (3424 non-demented, 355 dementia cases)                                  Mean age 48                                     30 years                                                                              \+
  Hu 2007                                                     Finland                               29335                                                                         25--64 years                                    18.9 years                                                                            \+
  Kesse-Guyot 2012                                            France                                3054                                                                          SD: 52.1                                        13.4 years                                                                            \-
  Laitala 2009                                                Finland                               2606                                                                          Mean age 46--52                                 28 years                                                                              ++
  Laitinen 2006                                               Finland                               1449                                                                          SD: 50.4                                        21 years                                                                              ++
  Laurin 2004                                                 US (Hawaii)                           2459                                                                          45--68 years (Mean: 51.2)                       30.2 years                                                                            \+
  Lehto 2013                                                  Finland                               2600                                                                          42--61 years                                    20.1 years                                                                            \+
  Liu 2003                                                    United States                         74091                                                                         38--63 years                                    12 years                                                                              \+
  Masaki 2003                                                 Japan                                 5644                                                                          40--69                                          10 years                                                                              \+
  Miura 2004                                                  United States                         1710                                                                          40--55 years (Mean 48.5)                        39 years                                                                              \+
  Nakamura 2009                                               Japan                                 2316                                                                          47--60 years                                    19 years                                                                              \+
  Nooyens 2011 (Doetinchem Cohort Study)                      Netherlands                           2613                                                                          43--70 years                                    10 years                                                                              \+
  Osler 2003                                                  Denmark                               7540                                                                          30--70 years                                    36 years                                                                              \+
  Ross 2000                                                   US Hawaii                             8004                                                                          45--68 years                                    30 years                                                                              \+
  Ruder 2011                                                  United States                         292797                                                                        40--61 years                                    10 years                                                                              ++
  Ruusanen 2010                                               Finland                               2232                                                                          42--60 years                                    17.5 years                                                                            \+
  Sabia 2009                                                  UK                                    5123                                                                          35--55 years                                    17 years                                                                              \+
  Samieri 2013                                                United States                         10670                                                                         Upper 50s, lower 60s (SD: 59)                   15.2 years                                                                            \+
  Seccareccia 2003                                            Italy                                 1536                                                                          45--65 years                                    30 years                                                                              \+
  Song 2006                                                   United States                         28349                                                                         45+ years                                       9.8 years                                                                             \+
  Strandhagen 2000                                            Sweden                                792                                                                           Age 54                                          26 years                                                                              ++
  Tsugane 2004                                                Japan                                 39065                                                                         40--59 years                                    11 years                                                                              \+
  Walda 2002                                                  Finland, Italy and The Netherlands    2917                                                                          50--69 years                                    20 years                                                                              \+
  Wang 2009                                                   United States                         38408                                                                         45+ years                                       11.5 years                                                                            \+
  Wang 2012                                                   United States                         28082                                                                         39+                                             12.9 years                                                                            \+
  Wang 2008                                                   United States                         28766                                                                         45+ years (SD 53.8)                             10 years                                                                              \+
  Xu 2010                                                     Australia                             564                                                                           45--60 years                                    5 years                                                                               \-
  **Smoking**                                                                                                                                                                                                                                                                                                           
  Agahi 2013                                                  Sweden                                1060                                                                          30--50                                          Up to 34yrs                                                                           \-
  Alonso 2009                                                 USA                                   11,151                                                                        45--64                                          Up to 10yrs                                                                           \+
  Baba 2006                                                   Japan                                 41,307                                                                        40-59yrs                                        11yrs                                                                                 \+
  Blanco-Cedres 2002                                          USA                                   8,816                                                                         40-59yrs                                        25yrs                                                                                 \+
  Boudik 2006                                                 Prague                                926 men                                                                       Mean 46.1 (Middle aged men)                     21yrs                                                                                 \-
  Britton 2008                                                England                               5823 (civil servant)                                                          35--55                                          17yrs                                                                                 \+
  Dubas 2007                                                  Sweden                                7388                                                                          47--55                                          28yrs ('70-'98)                                                                       ++
  Englund 2013                                                Sweden                                778                                                                           54±5.9                                          11.2±2.6                                                                              \+
  Fogelholm 2000                                              Finland                               1143                                                                          36--88                                          10 yrs ('85-'95)                                                                      \+
  Gerber 2012                                                 Israel                                4633                                                                          50.1±6.5                                        Median 26yrs (quartiles 1--3: 16--35)                                                 ++
  Halperin 2008                                               USA                                   13,529                                                                        52.4±8.9                                        Med 14.5yrs Max 20.5yrs                                                               \+
  Hara 2002                                                   Japan                                 41,484                                                                        40--59                                          Never: 64,986 PA Former: 42,798 PA Current: 103,537 PA                                \+
  Harmsen 2006                                                Sweden                                7457                                                                          Middle-age men                                  28yrs                                                                                 \+
  Holme 2007                                                  Norway                                6382(M)                                                                       40--49                                          28yrs                                                                                 \+
  Holmberg 2006                                               Sweden                                22444 (M) 10902(W)                                                            Men: 27--61 yrs. Women: 28--58 yrs              19yrs (M) 15yrs (W)                                                                   \+
  Humphries 2001                                              UK                                    3052 men                                                                      55.7±3.2                                        11yrs                                                                                 \+
  Inoue 2004                                                  Japan                                 92,792                                                                        40--69 (mean 53)                                10 yrs                                                                                \+
  Janzon 2004                                                 Sweden                                10619                                                                         49 yrs (28.3--57.6)                             14.0±4.5yrs (range 0.5--21.9 years)                                                   \+
  Khalili 2002                                                Sweden                                22 444 --(not clear)                                                          Mean 42.2                                       17yrs                                                                                 \+
  Kimm 2011                                                   Korea                                 3252                                                                          Men 51.9 ±8.7 Women 53.6 ±9.9                   14yrs                                                                                 \+
  Lim 2013                                                    Singapore                             48,251                                                                        45--74                                          93--98 to 2009                                                                        \-
  Mannami 2004                                                Japan                                 19,782 men and 21,500 women                                                   40--59                                          90--92 to 01 (total of 461,761 person-year follow-up)                                 ++
  Moayyeri 2009                                               UK                                    25,311                                                                        W: 64.7 (8.4) M: 61.9 (9.7) (40-75yrs)          11.3yrs (SD = 1.5; range 9.2--14.1)                                                   \+
  Nakayama 2000                                               Japan                                 998                                                                           40-64yrs                                        20yrs                                                                                 \+
  Noborisaka 2013                                             Japan                                 6998                                                                          Men 84.3% bt 30-59yrs Women 86.3% bt 30-59yrs   6 yrs                                                                                 \+
  Nooyens 2008                                                Netherlands                           1964                                                                          56.0 (7.0)                                      5yrs                                                                                  \+
  Nafziger 2007                                               Sweden                                82927                                                                         30--60                                          10 years                                                                              ++
  Östenson 2012                                               Sweden                                2382                                                                          47.2 (46.9--47.4)                               10 years                                                                              \+
  Ostbye 2002                                                 US                                    7,845                                                                         51--61 years                                    HRS: 6yrs                                                                             \-
  Otani 2003                                                  Japan                                 19,862 (cohort 1). 10,212 (cohort 2)                                          48.9 (6.0) (cohort 1). 53.4 (8.2) (cohort 2)    10yrs (cohort 1). 7yrs (cohort 2)                                                     \+
  Patja 2005                                                  Finland                               41 372                                                                        25--64                                          Mean follow-up 21 years                                                               \-
  Pelkonen 2000                                               Finland                               1582                                                                          Not reported                                    30yrs                                                                                 ++
  Qiao 2000                                                   Finland                               1673                                                                          Not reported                                    35yrs                                                                                 \+
  Qiu 2003                                                    China                                 50,069                                                                        55.3±11.8                                       6yrs                                                                                  \+
  Räikkönen 2001                                              USA                                   541                                                                           48.0±1.5                                        9.2yrs; SD, 3.4 years                                                                 \+
  Riserus 2007                                                Sweden                                770                                                                           50                                              20 yrs (70--73 to 91--95)                                                             \+
  Rusanen 2011                                                USA                                   21,123                                                                        50--60                                          17yrs                                                                                 \+
  Sabia 2008                                                  England                               5388                                                                          35--55                                          85--88 to 97--99                                                                      \+
  Sabia 2009                                                  England                               5123                                                                          Mean 56yrs                                      5yrs                                                                                  \+
  Satoh 2006                                                  Japan                                 2,764                                                                         35--44                                          10yrs                                                                                 \+
  Sairenchi 2004                                              Japan                                 39,528 men and 88,613 women                                                   40--79 (sub group: 40--59)                      93--02                                                                                \+
  Shaper 2003                                                 Britain                               7735                                                                          40--59                                          22yrs ('78-'00)                                                                       ++
  Sobue 2002                                                  Japan                                 91,738                                                                        40--69                                          9yrs                                                                                  ++
  Stevens 2009                                                England Scotland                      1.3 million                                                                   50--60 (women)                                  5-9yrs                                                                                ++
  Strand 2013                                                 Norway                                48,793                                                                        35--50                                          35yrs                                                                                 ++
  Strandberg 2008                                             Finland                               1658                                                                          40--55                                          26yrs                                                                                 \+
  Szoeke 2006                                                 Australia                             438                                                                           46--52                                          11 years                                                                              \+
  Tyas 2003                                                   Hawaii                                3734                                                                          (mid-life)                                      ('65--'71) and ('91--'96)                                                             \+
  Whitmer 2005                                                USA                                   8,845                                                                         40--44                                          27yrs ('64-'03)                                                                       \+
  Wilcox 2006                                                 USA                                   5820 Japanese American men                                                    Mean 54yrs (45--68)                             Up to 40yrs                                                                           ++
  Wannamethe 2001                                             UK                                    7735                                                                          40--59                                          16.8 yrs                                                                              \+
  **Alcohol**                                                                                                                                                                                                                                                                                                           
  Anttila 2004                                                Finland                               632 women and 386 men                                                         Mean age 48.3 yrs                               1972--77 to 1998                                                                      \+
  Beulens 2007                                                Netherlands                           1,417                                                                         49--70 yrs                                      1993--97 to 2005                                                                      ++
  Elwood 2013                                                 Caerphilly, UK                        1,320 men                                                                     45--59                                          1979--04                                                                              \+
  Emberson 2005                                               England,Wales, and Scotland           7,735                                                                         40--59                                          1978/1980 to 1998/2000                                                                ++
  Englund 2013                                                Sweden                                778                                                                           49--61                                          85--08                                                                                \+
  Flood 2008                                                  USA                                   49238                                                                         Older than 50 y                                 1995--1996 to 2000                                                                    ++
  Iso 2004                                                    Japan                                 19 544                                                                        40--59                                          1990--2000                                                                            \+
  Lin 2005                                                    Japan                                 110,792                                                                       40 to 79 years                                  1988--1990 to 1999                                                                    ++
  Moayyeri 2009                                               UK                                    25311                                                                         40--75 years                                    1993--1997 to 2007                                                                    \+
  Ostbye 2002                                                 US                                    HRS study: 7,845 people                                                       HRS study: ages 51--61 yrs                      HRS: 92--98                                                                           \-
  Otani 2003                                                  Japan                                 90004                                                                         40--59 Cohort 1. 40--69 Cohort 2                Cohort I. After January 1, 1990--1999. Cohort II. January 1, 1993--1994--1999         \+
  Qiu 2003                                                    China                                 50069                                                                         40--80+                                         1994/1996-2000                                                                        \+
  Sabia 2009                                                  England                               5,123                                                                         Mean age 56 yrs                                 97--99 to 02--04                                                                      \+
  Sabia 2011                                                  France                                4073 men                                                                      Ages 40--50 for men and 35--50 for women        10 yrs (1992 to 2002--04)                                                             \+
  Stevens 2009                                                England and Scotland                  1.29 million women                                                                                                            96--01 to 05--07 Mean yrs of follow-up: 7.2 for cancer incidence; 8.9 for mortality   \+
  Sun 2011                                                    US                                    13,894                                                                        70+                                             84--00                                                                                ++
  Tabak 2001                                                  Finland, Italy, Netherlands           2,953 men (Finland: 1,186 men; Italy: 1,183; Netherlands: 667)                40--59                                          20 yrs (1965--70 to 1990)                                                             \-
  Virta 2010                                                  Finland                               1,486                                                                         Mean age in 1981: 51.7 yrs (SD: 6.1)            1975--81 to 1999--07 (mean follow-up: 22.8 yrs.)                                      ++
  Wannamethee 2002                                            England,Wales, and Scotland           7157                                                                          40-59yrs                                        ('78--'80)-(2000)                                                                     \+
  Waki 2005                                                   Japan                                 28,893                                                                        40--59 yrs                                      10 yrs (baseline: 1990)                                                               \+
  Wannamethee 2003                                            England, Wales, Scotland              7,608 men                                                                     40--59 yrs                                      1978--80 to 1983--85                                                                  \+
  Wang 2010                                                   US                                    19,220                                                                        38--89 yrs                                      12.9 yrs. follow-up (baseline: 1992--95)                                              \+
  Willcox 2006                                                Island of Oahu                        5820                                                                          45-68yrs                                        Not reported                                                                          ++
  Xu 2010                                                     South East Queensland, Australia      564                                                                           45--60 yrs                                      2001--06                                                                              \-
  **Weight Change/Weight Cycling**                                                                                                                                                                                                                                                                                      
  Field 2009                                                  United States                         44842                                                                         30--55                                          16 years                                                                              \+
  Langlois 2001                                               United States                         2180                                                                          50--74                                          22 years                                                                              ++
  Ravona-Springer 2013                                        Israel                                10000                                                                         40--70                                          36 years                                                                              \+
  Waring 2010                                                 United States                         1577                                                                          40--50                                          11 years                                                                              ++
  Agrigoroaei 2011                                            United States                         4995                                                                          33--84                                          9--10 years                                                                           ++
  Elwood 2013                                                 Caerphilly, UK                        1,320 men                                                                     45--59                                          1979--04                                                                              \+
  King 2007                                                   United States                         15708                                                                         45--64                                          11--13 years                                                                          ++
  **Leisure/Cognitive Activity/Social Networks**                                                                                                                                                                                                                                                                        
  Bielak 2012                                                 Australia                             7152                                                                          20--24: 2404, 40--44: 2530, 60:64: 2551         7 years                                                                               ++
  Britton 2008                                                UK (England)                          5823                                                                          35--55                                          17 years                                                                              \+
  Friedland 2001                                              United States                         193 cases/358 controls (for total study, not reported for 40--59 year olds)   40--59                                          \>12 (not fully reported)                                                             \-
  Holtzman 2004                                               United States                         354                                                                           50+                                             12.4 years                                                                            ++
  Kareholt 2011                                               Sweden                                1643                                                                          57.4                                            20+ years                                                                             ++
  Raikkonen 2001                                              United States                         541                                                                           42--50                                          9.2 years                                                                             ++

**Guide: i**. Data is from multivariate models. Where multiple models have been reported data from the most adjusted (or most relevant) model has been used. **ii. Results**: + = significant positive association, -- = significant inverse association, 0 = no significant association; √ = study that shows improved outcomes; X = study that shows poorer outcomes. **iii. Quality of study \[++/+/-\]**. ++ = high quality; + = moderate quality; - = low quality.

Note 1: A positive association (+) with PA is the better outcome

Note: 2 Physical inactivity where multiple outcomes have reported the most adjusted data in this table; sig = p\</ = 0.05; ns = not significant (p\>0.05)

Note 3: A positive association (+) with smoking is a worst outcome

Note 4: A positive association (+) with alcohol is the worst outcome

Longitudinal associations have been tabulated and synthesised narratively. Data specific to health inequalities has been summarised separately. Due to the methodological and statistical heterogeneity it was not appropriate to conduct a meta-analysis.

Results {#sec016}
=======

Search Results {#sec017}
--------------

The searches for primary studies and the grey literature located 10,338 articles after removing duplicates, 567 of which had relevant titles and abstracts. In total, 164 observational longitudinal cohort studies were included in the review ([Fig 1](#pone.0144405.g001){ref-type="fig"}). The behavioural risk factors for which we found published data in mid-life with relevant outcomes in later life were: physical activity and inactivity; diet; tobacco consumption; alcohol; weight change or weight cycling; leisure, cognitive activity or social networks; and combinations of the above. Studies of behaviour related to hearing or vision were sought, but none met the inclusion criteria.

Quality {#sec018}
-------

Overall, the quality of studies is good (most studies were rated as high or moderate quality). Summary quality scores can be found in [Table 1](#pone.0144405.t001){ref-type="table"}. Full quality assessments can be found in [S2 Table](#pone.0144405.s002){ref-type="supplementary-material"}.

Characteristics of included studies {#sec019}
-----------------------------------

Summary characteristics for studies by health behaviours are listed in [Table 1](#pone.0144405.t001){ref-type="table"}. Forty-five papers were found relating to mid-life physical activity (PA) or inactivity, 48 for diet, 57 for smoking and 24 for alcohol. Four studies were included that reported an association between weight change patterns in mid-life and later outcomes. Three studies reported data for combinations of lifestyle behaviours. Four studies were found that examined the relationship between mid-life leisure/social activities and DDF outcomes. The data relating studies found and health behaviour is reported in [Table 2](#pone.0144405.t002){ref-type="table"}.

10.1371/journal.pone.0144405.t002

###### Exposure and Outcomes.

![](pone.0144405.t002){#pone.0144405.t002g}

                                                  Physical activity and physical inactivity                                                                                                                                                                                                                                                Diet                                                                                                                                                                                                                             Smoking                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Alcohol                                                                                                                                                                                               Weight change and cycling    Combined                                                 Leisure/cognitive activity/social networks
  ----------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------- -------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------
  Healthy Ageing / Quality of Life / Well-being   \[[@pone.0144405.ref030]\]; \[[@pone.0144405.ref039]\]; \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref059]\]; \[[@pone.0144405.ref031]\]; \[[@pone.0144405.ref038]\]; \[[@pone.0144405.ref042]\]; \[[@pone.0144405.ref037]\]; \[[@pone.0144405.ref032]\]                               \[[@pone.0144405.ref071]\]; \[[@pone.0144405.ref030]\]; \[[@pone.0144405.ref115]\]; \[[@pone.0144405.ref112]\]; \[[@pone.0144405.ref116]\]; \[[@pone.0144405.ref072]\]                                                           \[[@pone.0144405.ref120]\]; \[[@pone.0144405.ref030]\]; \[[@pone.0144405.ref163]\]; \[[@pone.0144405.ref121]\]; \[[@pone.0144405.ref147]\]; \[[@pone.0144405.ref122]\]; \[[@pone.0144405.ref148]\]; \[[@pone.0144405.ref207]\]; \[[@pone.0144405.ref209]\]; \[[@pone.0144405.ref037]\]; \[[@pone.0144405.ref118]\]                                                                                                                                                                            \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref032]\]; \[[@pone.0144405.ref173]\]; \[[@pone.0144405.ref174]\]                                                                                        No evidence was identified   No evidence was identified                               \[[@pone.0144405.ref030]\]
  Disability / Frailty                            \[[@pone.0144405.ref034]\]; \[[@pone.0144405.ref041]\]; \[[@pone.0144405.ref040]\]; \[[@pone.0144405.ref049]\]; \[[@pone.0144405.ref033]\]; \[[@pone.0144405.ref035]\]; \[[@pone.0144405.ref037]\]; \[[@pone.0144405.ref036]\]; \[[@pone.0144405.ref043]\]                               \[[@pone.0144405.ref060]\]; \[[@pone.0144405.ref073]\]; \[[@pone.0144405.ref117]\]                                                                                                                                               \[[@pone.0144405.ref120]\]; \[[@pone.0144405.ref040]\]; \[[@pone.0144405.ref059]\]; \[[@pone.0144405.ref043]\]                                                                                                                                                                                                                                                                                                                                                                                \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref040]\]; \[[@pone.0144405.ref122]\]; \[[@pone.0144405.ref037]\];                                                                                       \[[@pone.0144405.ref177]\]   \[[@pone.0144405.ref046]\]                               \[[@pone.0144405.ref181]\]
  Dementia & Cognition                            \[[@pone.0144405.ref044]\]; \[[@pone.0144405.ref048]\]; \[[@pone.0144405.ref047]\]; \[[@pone.0144405.ref133]\]; \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref131]\]; \[[@pone.0144405.ref050]\]; \[[@pone.0144405.ref045]\]; \[[@pone.0144405.ref051]\]; \[[@pone.0144405.ref052]\]   \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref074]\]; \[[@pone.0144405.ref080]\]; \[[@pone.0144405.ref076]\]; \[[@pone.0144405.ref079]\]; \[[@pone.0144405.ref078]\]; \[[@pone.0144405.ref081]\]; \[[@pone.0144405.ref052]\]   \[[@pone.0144405.ref026]\]; \[[@pone.0144405.ref126]\]; \[[@pone.0144405.ref134]\]; \[[@pone.0144405.ref125]\]; \[[@pone.0144405.ref129]\]; \[[@pone.0144405.ref052]\]; \[[@pone.0144405.ref132]\]; \[[@pone.0144405.ref127]\]; \[[@pone.0144405.ref124]\]                                                                                                                                                                                                                                    \[[@pone.0144405.ref165]\]; \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref052]\]; \[[@pone.0144405.ref166]\]; \[[@pone.0144405.ref164]\];                                                           \[[@pone.0144405.ref178]\]   \[[@pone.0144405.ref184]\]; \[[@pone.0144405.ref046]\]   \[[@pone.0144405.ref181]\]; \[[@pone.0144405.ref049]\]; \[[@pone.0144405.ref182]\]; \[[@pone.0144405.ref183]\]
  Overall mortality                               \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref057]\]; \[[@pone.0144405.ref054]\]; \[[@pone.0144405.ref053]\]; \[[@pone.0144405.ref055]\]; \[[@pone.0144405.ref161]\]; \[[@pone.0144405.ref056]\]                                                                                       \[[@pone.0144405.ref071]\]; \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref082]\]; \[[@pone.0144405.ref075]\]; \[[@pone.0144405.ref085]\]; \[[@pone.0144405.ref084]\]; \[[@pone.0144405.ref083]\]                               \[[@pone.0144405.ref140]\]; \[[@pone.0144405.ref137]\]; \[[@pone.0144405.ref152]\]; \[[@pone.0144405.ref139]\]; \[[@pone.0144405.ref134]\]; \[[@pone.0144405.ref132]\]; \[[@pone.0144405.ref118]\]; \[[@pone.0144405.ref119]\]                                                                                                                                                                                                                                                                \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref167]\]; \[[@pone.0144405.ref168]\]; \[[@pone.0144405.ref119]\];                                                                                       \[[@pone.0144405.ref179]\]   \[[@pone.0144405.ref046]\]                               No evidence was identified
  Cardiovascular (CVD) Outcomes                   \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref057]\]; \[[@pone.0144405.ref062]\]; \[[@pone.0144405.ref053]\]; \[[@pone.0144405.ref060]\]; \[[@pone.0144405.ref028]\]; \[[@pone.0144405.ref061]\]; \[[@pone.0144405.ref056]\]                                                           \[[@pone.0144405.ref071]\]; \[[@pone.0144405.ref097]\]; \[[@pone.0144405.ref098]\]; \[[@pone.0144405.ref096]\]; \[[@pone.0144405.ref111]\]; \[[@pone.0144405.ref100]\];                                                          \[[@pone.0144405.ref027]\]; \[[@pone.0144405.ref141]\]; \[[@pone.0144405.ref142]\]; \[[@pone.0144405.ref153]\]; \[[@pone.0144405.ref140]\]; \[[@pone.0144405.ref150]\]; \[[@pone.0144405.ref137]\]; \[[@pone.0144405.ref154]\]; \[[@pone.0144405.ref149]\]; \[[@pone.0144405.ref152]\]; \[[@pone.0144405.ref139]\]; \[[@pone.0144405.ref147]\]; \[[@pone.0144405.ref138]\]; \[[@pone.0144405.ref135]\]; \[[@pone.0144405.ref089]\]; \[[@pone.0144405.ref151]\]; \[[@pone.0144405.ref146]\];   \[[@pone.0144405.ref093]\]; \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref167]\]; \[[@pone.0144405.ref171]\]; \[[@pone.0144405.ref089]\]; \[[@pone.0144405.ref169]\]; \[[@pone.0144405.ref170]\];   No evidence was identified   \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref186]\]   \[[@pone.0144405.ref151]\]
  Diabetes / Metabolic Syndrome                   \[[@pone.0144405.ref065]\]; \[[@pone.0144405.ref063]\]; \[[@pone.0144405.ref064]\]; \[[@pone.0144405.ref066]\]                                                                                                                                                                           \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref106]\]; \[[@pone.0144405.ref066]\]; \[[@pone.0144405.ref104]\]; \[[@pone.0144405.ref105]\]; \[[@pone.0144405.ref102]\];                                                          \[[@pone.0144405.ref063]\]; \[[@pone.0144405.ref149]\]; \[[@pone.0144405.ref158]\]; \[[@pone.0144405.ref155]\]; \[[@pone.0144405.ref066]\]; \[[@pone.0144405.ref156]\]; \[[@pone.0144405.ref068]\]                                                                                                                                                                                                                                                                                            \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref172]\]                                                                                                                                                \[[@pone.0144405.ref180]\]   \[[@pone.0144405.ref046]\]                               No evidence was identified
  Cancer                                          \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref068]\]                                                                                                                                                                                                                                   \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref107]\]; \[[@pone.0144405.ref108]\]; \[[@pone.0144405.ref083]\]; \[[@pone.0144405.ref109]\]                                                                                       \[[@pone.0144405.ref162]\]; \[[@pone.0144405.ref159]\]; \[[@pone.0144405.ref160]\]; \[[@pone.0144405.ref161]\];                                                                                                                                                                                                                                                                                                                                                                               \[[@pone.0144405.ref046]\]; \[[@pone.0144405.ref176]\]; \[[@pone.0144405.ref159]\]; \[[@pone.0144405.ref161]\];                                                                                       No evidence was identified   \[[@pone.0144405.ref046]\]                               No evidence was identified
  Mental health                                   \[[@pone.0144405.ref069]\]; \[[@pone.0144405.ref070]\];                                                                                                                                                                                                                                  \[[@pone.0144405.ref114]\]; \[[@pone.0144405.ref113]\]; \[[@pone.0144405.ref070]\]                                                                                                                                               \[[@pone.0144405.ref120]\]                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \[[@pone.0144405.ref070]\]                                                                                                                                                                            No evidence was identified   No evidence was identified                               No evidence was identified

Exposures were measured a number of different ways in the included studies. For physical activity all studies used self-reports of activity except one, which used an accelerometer. Dietary data was also self-reported through interview and food questionnaires. For smoking, many studies used self-reports with questionnaires and interviews with a number of studies using biochemical testing to confirm smoking status. All studies assessing the impact of alcohol, weight change/weight cycling and leisure and social activities used self-administered lifestyle questionnaires and interviews. The outcome and exposure measures are comprehensively reported in [S4 Table](#pone.0144405.s004){ref-type="supplementary-material"}.

Only four studies explicitly examining health inequalities were identified: three looking at gender or ethnicity \[[@pone.0144405.ref026]--[@pone.0144405.ref028]\] and one at lower socioeconomic status groups \[[@pone.0144405.ref029]\].

### Summary of health behaviours and outcomes {#sec020}

A full summary of studies, exposures and outcomes are reported in [S3 Table](#pone.0144405.s003){ref-type="supplementary-material"}. An overview of reported outcomes in relation to health behaviours is shown in Tables [3](#pone.0144405.t003){ref-type="table"} and [4](#pone.0144405.t004){ref-type="table"}. Due to the large volume of data found only the main findings are reported below.

10.1371/journal.pone.0144405.t003

###### Overall Summary of Studies.

![](pone.0144405.t003){#pone.0144405.t003g}

  Results:                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  ------------------------------------------------------ -------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------- ------------------------------- ---------------------------------------------------- --------------------------------------- --------------------------------------------- ---------------------------------- ------------
  **Physical Activity**                                                                                                                                                                                                                                                                                                                                                                                                                                            
  √√√                                                    √√√√√ 0                                                  √√√√√√ 00                                                                                                                          √√√√√                           √√√√√√√√√                                            √√√√√                                   √√ X 000                                                                         √ 0
  **Physical Inactivity**                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                         0                                                                                                                                                                                           0                               X0                                                                                                                                                                            
  **Tobacco**                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  XXX                                                    XX (mobility) 0X0X (fract)                               XXXXXX (dementia) 00XXX (cognition)                                                                                                X(XXX)XXX √√√√√√ (Ex-smokers)   XXXXXX0 (mortality) XXXXXXXXXXX0 (CVD)               XXX0 (Dia) X0 (MetS)                    XXXXXX (lung, pancreatic,colorectal,cancer)   X (kidney disease) 0 (ex smoker)   No studies
  **Smokeless Tobacco**                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                          √ (insulin, weight)                                                                                                      
  **Alcohol**                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  √X                                                     X (ADL)0X (fract)                                        X0 (dementia APOE4) 0 (cognition) XX (Abstainers (compared to mod or infreq) XXX Heavy drinkers (APOE4 compared to non-drinkers)   X                               000 XX (Heavy cf occasional) √ (Reg cf occasional)   X (Diabetes---mod or high) X0√ (MetS)   000X                                          0 (COPD)                           √
  **Weight Change**                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                         X (hip fracture) [Weight loss of \> 10% from max]{.ul}   X Weight variability                                                                                                               0 Weight cycling                                                                     X Weight cycling when OW at midlife                                                                                      
  **Leisure, Cognitive Activities and Social Network**                                                                                                                                                                                                                                                                                                                                                                                                             
  0                                                      0                                                        √ (dementia) √√√ (cognition)                                                                                                                                                                                                                                                                                                                     
  **Combined Lifestyle**                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                  √0 (cog)                                                                                                                           √ √                             √0                                                   0                                       0                                                                                

Key: 0 = no significant association; √ = study that shows improved outcomes; X = study that shows poorer outcomes

10.1371/journal.pone.0144405.t004

###### Overall Summary of Studies of Diet and Dietary Component.

![](pone.0144405.t004){#pone.0144405.t004g}

  Results:                                                                                                             
  ------------------------- ---- ----------------- ----- ------ --------------------------- --------------- ----- ---- ---
  Healthy dietary pattern   √√   √                                                          √               0          √
  Mediterranean diet        √                                   √√                                                     √
  Western diet              X                                                                                          
  Fruit and vegetables           √ 0 0             √ 0   √√ 0   √ 0                         0               0 0   √    
  Fat (saturated)                X                 X            0                           X                          
  Fat (polyunsaturated)                            √            0                                                      
  Fat (monounsat)                                               0                                                      
  Fat (total)                                                   0                                           X          
  Fish                                                   X      √ 0                         √ women 0 men         √    
  Meat                           √ (\>1 per 2 d)                √ (1-2/wk)                                             
  Red and processed meat                                        X                           X               X X        
  Coffee                         0                 √ 0          X (heavy)                   √√                    √√   0
  Tea                                                                                                             √    0
  Caffeine                                                                                                        √    0
  Milk                                                                                                      √          
  Salt                                                                                                      X          
  Glycaemic index/GL                                            √0                                                     
  Protein                                                       0                                           0          
  Chocolate                                                     √ (1--3 times/month only)                              
  Fibre                                                                                                     0          
  Micronutrients                                   0                                                        √          0
  Flavonoids                                       0            √                                           0          

Key: 0 = no significant association; √ = study that shows improved outcomes; X = study that shows poorer outcomes

The impact of physical activity (PA) and physical inactivity (PI) {#sec021}
-----------------------------------------------------------------

Summary data for physical activity, physical inactivity and sedentary behaviour studies, including study location, duration, period of follow-up, effect sizes, and quality scores are reported in [Table 3](#pone.0144405.t003){ref-type="table"}. Note that we found no studies specifically looking at the consequences of physical inactivity or sedentary behaviour for dementia and cognition outcomes, diabetes/metabolic syndrome, or mental health.

### Healthy ageing and well-being {#sec022}

There is consistent evidence \[[@pone.0144405.ref030]--[@pone.0144405.ref032]\] that PA in mid-life is positively associated with healthy and successful ageing outcomes. Healthy ageing or successful survival was defined in the three included studies as having no history of major chronic diseases and no cognitive impairment, physical impairment, or mental health limitations. No studies specifically aimed to assess physical inactivity; most studies reported physical activity in quintiles so reported lower levels of PA indirectly. No studies we found assessed quality of life.

### Disability/frailty {#sec023}

There is consistent evidence that PA in mid-life is related to more positive outcomes in terms of disability and frailty in later life. Five of the six studies reported beneficial associations between mid-life PA and physical mobility \[[@pone.0144405.ref033]\] or physical functioning \[[@pone.0144405.ref034]\] or disability \[[@pone.0144405.ref035]--[@pone.0144405.ref037]\]. One study \[[@pone.0144405.ref038]\] reported no significant association with disability. Another study \[[@pone.0144405.ref039]\] found no association between inactivity in leisure time PA in mid-life and disability at age 75.

Three studies reported on the association between mid-life PA and bone fractures or bone health. One study reported less risk of hip or wrist fractures \[[@pone.0144405.ref040],[@pone.0144405.ref041]\]. One reported improved bone mineral density in those who took part in PA in mid-life \[[@pone.0144405.ref042]\], and another reported no significant association with the risk of osteoarthritis \[[@pone.0144405.ref043]\].

### Dementia & cognition {#sec024}

There is consistent evidence that PA in mid-life is associated with lower risk of dementia or better cognitive function in later life. Of the six prospective studies reporting on dementia or Alzheimer's disease, four studies reported a significant beneficial association \[[@pone.0144405.ref044]--[@pone.0144405.ref047]\] and four studies non-significant associations \[[@pone.0144405.ref048]--[@pone.0144405.ref051]\]. Two studies found a significant inverse association between light and regular PA, but not for heavy PA \[[@pone.0144405.ref047],[@pone.0144405.ref049]\]. Two studies found a positive association between mid-life PA and improved cognitive function in later life \[[@pone.0144405.ref034],[@pone.0144405.ref052]\].

### Overall mortality {#sec025}

There is consistent evidence \[[@pone.0144405.ref046],[@pone.0144405.ref053]--[@pone.0144405.ref056]\] that regular, moderate and high intensity PA in mid-life is related to lower mortality in later life. One study \[[@pone.0144405.ref046],[@pone.0144405.ref056]\] reports lower all-cause mortality but another \[[@pone.0144405.ref057]\] found no significant relationship between leisure time inactivity in mid-life and all-cause mortality.

### Cardiovascular outcomes {#sec026}

There is strong evidence \[[@pone.0144405.ref028],[@pone.0144405.ref046],[@pone.0144405.ref053],[@pone.0144405.ref054],[@pone.0144405.ref058]--[@pone.0144405.ref062]\] of the beneficial effect of mid-life PA on CVD events or mortality. Six papers reported a significant association between mid-life PA and stroke \[[@pone.0144405.ref059]\], CVD risk \[[@pone.0144405.ref056],[@pone.0144405.ref062]\], coronary heart disease (CHD) events \[[@pone.0144405.ref054],[@pone.0144405.ref056],[@pone.0144405.ref060]\], myocardial infarction \[[@pone.0144405.ref028]\], ischaemic heart disease \[[@pone.0144405.ref054]\] and three papers reported lower CVD-related mortality from stroke \[[@pone.0144405.ref061]\], CHD \[[@pone.0144405.ref056]\] and CVD \[[@pone.0144405.ref053]\] related to PA in mid-life.

Another \[[@pone.0144405.ref057]\] found a significant positive relationship between a single item measure of leisure time inactivity in mid-life and CVD mortality. However, no significant association was found when an index measure of leisure time physical activity was used.

### Diabetes/metabolic syndrome {#sec027}

There is some consistent evidence that PA in mid-life is related to lower incidence of diabetes in later life \[[@pone.0144405.ref046],[@pone.0144405.ref060],[@pone.0144405.ref063],[@pone.0144405.ref064]\]. In addition, three studies reported a beneficial association between mid-life PA and diabetes preconditions, two reported metabolic syndrome \[[@pone.0144405.ref063],[@pone.0144405.ref065]\] and one reported insulin sensitivity \[[@pone.0144405.ref066]\].

### Impact on cancer {#sec028}

The evidence relating to the associations between PA in mid-life and cancer is mixed. Four studies \[[@pone.0144405.ref046],[@pone.0144405.ref053],[@pone.0144405.ref066],[@pone.0144405.ref067]\] reported longitudinal associations between mid-life physical activity and cancer or cancer mortality; however no significant relationship between mid-life PA and incident and fatal pancreatic cancer \[[@pone.0144405.ref067]\], lung, stomach, colorectal, lymphatic/hematopoietic cancers \[[@pone.0144405.ref068]\], or cancer mortality \[[@pone.0144405.ref053],[@pone.0144405.ref068]\] was observed. One study \[[@pone.0144405.ref068]\] found lower rates of total cancer, upper digestive tract cancers (oral, oesophagus, stomach cancer) in those who participated in moderate or vigorous PA at mid-life, and increased risk of bladder cancer in those who participated in vigorous exercise compared to those who did not. Conversely, total cancer mortality was lower in those who took part in moderate or high levels of PA \[[@pone.0144405.ref046]\].

### Impact on mental health {#sec029}

The evidence for an association between mid-life PA and mental health is inconclusive. One prospective cohort study \[[@pone.0144405.ref069]\] reported less risk of anxiety and/or depression for heavy PA at five-year follow-up but not at 10 years. Another study \[[@pone.0144405.ref070]\] found no significant association between mental well-being, including anxiety and depression and mid-life PA.

The impact of overall diet and dietary patterns {#sec030}
-----------------------------------------------

Summary data, including study location, duration, period of follow-up, effect sizes, and quality scores for overall diet and dietary patterns is reported in [Table 4](#pone.0144405.t004){ref-type="table"}.

### Healthy ageing/quality-of-life/well-being {#sec031}

There is consistent evidence \[[@pone.0144405.ref030],[@pone.0144405.ref071],[@pone.0144405.ref072]\] that a 'healthy' diet in mid-life is related to healthy and successful ageing. A Mediterranean type diet is associated with more successful ageing \[[@pone.0144405.ref072]\]. A Western dietary pattern (characterised by high intakes of fried and sweet food, processed food and red meat, refined grains, and high-fat dairy products) was associated with less successful ageing. In these studies healthy ageing is defined as no major chronic diseases or major impairments in cognitive or physical function or mental health. No studies we found assessed quality of life or wellbeing.

### Disability/frailty {#sec032}

There is limited evidence that 'healthy' diet or dietary patterns in mid-life is related to better functioning. One study reported associations between mid-life diet and ADL \[[@pone.0144405.ref073]\], in which men who ate meat at least once every two days or more were less likely to have impairment in ADL.

### Dementia & cognition {#sec033}

There is limited evidence that 'healthy' diet or dietary patterns in mid-life is related to dementia and cognitive functioning in later life. Two studies reported beneficial associations between fruit and vegetable intake in mid-life and dementia \[[@pone.0144405.ref046],[@pone.0144405.ref074]\]. Two studies examined relationships between coffee consumption in mid-life and dementia \[[@pone.0144405.ref075]--[@pone.0144405.ref077]\]. One study reported that moderate coffee consumption was associated with lower risk of dementia, but not tea drinking \[[@pone.0144405.ref075],[@pone.0144405.ref077]\]. Another found no significant association with dementia \[[@pone.0144405.ref076]\]. One reported a non-significant relationship between mid-life dietary antioxidant intake, flavonoids and dementia \[[@pone.0144405.ref078]\]. A greater risk of dementia was also reported in those consuming moderate compared to low amounts of saturated fat compared to those consuming moderate compared to low amounts of polyunsaturated fat \[[@pone.0144405.ref079]\].

One study reported better cognitive outcomes for those consuming a 'healthy pattern' diet \[[@pone.0144405.ref080]\], characterised as consumption of fruit, whole grains, vegetables, and negatively correlated with meat and poultry, refined grains, animal fat, and processed meat. More than two portions of fruit and vegetables a day was associated with better cognitive performance \[[@pone.0144405.ref052]\]; however, two studies reported no significant association with cognitive function \[[@pone.0144405.ref046],[@pone.0144405.ref081]\]. Higher levels of total or saturated fat were associated with greater cognitive impairment in later life \[[@pone.0144405.ref082]\].

### Overall mortality {#sec034}

The evidence on the impact of diet/dietary patterns on mortality is mixed. Three studies reported associations between fruit and/or vegetable intake and total mortality. One reported significantly lower risk of death in people consuming higher levels of fruit and vegetables at mid-life \[[@pone.0144405.ref083]\], another reported significantly lower overall mortality for each increase of 20g/day in vegetable intake \[[@pone.0144405.ref084]\]. Associations between \>3 portions fruit and vegetables/day were not significant in one study \[[@pone.0144405.ref046]\]. There is limited evidence for increased mortality with greater fish consumption in those at high risk of CHD \[[@pone.0144405.ref085]\].

### Cardiovascular outcomes {#sec035}

Evidence suggests a healthy diet has a positive impact on cardiovascular outcomes. Two studies reported beneficial effects of a Mediterranean diet pattern with lower risk of CHD events and mortality \[[@pone.0144405.ref086],[@pone.0144405.ref087]\]. One reported fruit and vegetable intake was associated with lower CVD mortality \[[@pone.0144405.ref083]\]; however another \[[@pone.0144405.ref046]\] reported non-significant associations. Findings from one study \[[@pone.0144405.ref088]\] suggest that high intakes of flavonoids may be associated with decreased risk of ischaemic stroke and possibly with reduced CVD mortality.

One study \[[@pone.0144405.ref089]\] reported lower risk of cerebrovascular disease in those consuming meat one-two times a month compared to those consuming no meat or those who ate meat more than once a week. A lower risk of CHD events and mortality was found in women when meat was replaced with fish \[[@pone.0144405.ref090]\]. Another study reported no significant association between fatty fish consumption and heart failure but lower risk of heart failure in those consuming marine omega 3 fatty acids once a week \[[@pone.0144405.ref091]\]. Higher intakes of marine omega 3 fatty acids were not significantly associated with heart failure.

Heavier coffee drinkers showed a higher risk of CHD events and mortality compared to moderate coffee drinkers \[[@pone.0144405.ref092]\]. Associations were not significant for light or no coffee drinking compared to moderate intake.

A higher risk of CVD was reported for those consuming diets with the highest compared to the lowest dietary glycaemic index and glycaemic load \[[@pone.0144405.ref093]\]. In another study associations between glycaemic index and glycaemic load, and CVD events were not significant \[[@pone.0144405.ref091]\]. One study found no significant associations between mid-life protein intake and ischemic heart disease \[[@pone.0144405.ref094]\].

One study reported no significant associations between total, saturated, monounsaturated or polyunsaturated fat and fatal or non-fatal cardiovascular events \[[@pone.0144405.ref095]\].

Fruit and possibly vitamin E intake may also have protective effects against COPD \[[@pone.0144405.ref096]\]. In men, diets higher in fruits and vegetables and lower in meats (except fish) may reduce the risk of developing high blood pressure \[[@pone.0144405.ref097]\]. In women results of one study \[[@pone.0144405.ref098]\] suggest that higher intake of dietary magnesium may have a modest effect on the development of hypertension. Intakes of low-fat dairy products, calcium, and vitamin D were each inversely associated with risk of hypertension in middle-aged and older women \[[@pone.0144405.ref099]\]. While higher intake of all fruits (but not all vegetables) was significantly associated with reduced risk of hypertension in women \[[@pone.0144405.ref100]\]; higher intake of saturated fats, monounsaturated fats, and trans fats were each associated with increased risk of hypertension among middle-aged and older women \[[@pone.0144405.ref101]\].

### Diabetes/metabolic syndrome {#sec036}

The evidence for the impact of diet on diabetes and metabolic syndrome is mixed. One study reported that a dietary pattern low in staples and high in milk was associated with lower risk of diabetes \[[@pone.0144405.ref102]\]. Another reported no statistically significant association between fruit and vegetables and diabetes \[[@pone.0144405.ref046]\]. Higher saturated fat intake at mid-life was associated with lower insulin sensitivity \[[@pone.0144405.ref066]\]. One study \[[@pone.0144405.ref103]\] reported lower risk of diabetes in women eating moderate and high amounts of fish and shellfish with a significant trend with greater fish and shellfish intake. One study found increased risk of diabetes in those consuming higher levels of red and processed meat with a significant trend from lower to higher intake \[[@pone.0144405.ref104]\].

Two studies reported lower risk of diabetes with coffee intake. One conducted on men and women found a significant trend towards lower risk for diabetes with increasing coffee consumption \[[@pone.0144405.ref105]\]. The other \[[@pone.0144405.ref106]\] reported a significant inverse relationship for women consuming three or more cups of coffee a day with a significant trend. In men only one-two cups/day was significantly associated with lower risk of diabetes but there was also a significant inverse trend between coffee consumption and diabetes.

### Impact on cancer {#sec037}

There is inconsistent evidence regarding the impact of diet/dietary patterns on cancers. One study \[[@pone.0144405.ref107]\] found no clear associations between four dietary patterns and cancer. Two studies reported no significant associations between fruit and vegetables and cancer incidence or mortality \[[@pone.0144405.ref046],[@pone.0144405.ref083]\]. One study reported lower risk of colorectal cancer with consumption of fruit, dietary calcium, vitamin A and vitamin C; but higher risk of colorectal cancer with consumption of red and processed meat \[[@pone.0144405.ref108]\]. The study reported lower incidence of colorectal and rectal cancer in those consuming high volumes of milk but found no significant associations between protein and fibre intake with colorectal cancer. Another study \[[@pone.0144405.ref109]\] found a significant association between high salt intake and higher risk of gastric cancer in men but not women. One \[[@pone.0144405.ref110]\] reported lower risk of heart failure when chocolate was consumed 1--3 times month compared to no chocolate consumption. There is no significant relationship reported between flavonoids and total cancer or site-specific cancers \[[@pone.0144405.ref111]\].

### Impact on mental health {#sec038}

There is limited evidence regarding the impact on mental health. One study \[[@pone.0144405.ref112]\] reported less psychological distress in those with the highest compared to lowest adherence to the Mediterranean diet. Light or heavy coffee consumption was also associated with lower risk of severe depression \[[@pone.0144405.ref113]\]. However, one \[[@pone.0144405.ref070]\] reported no significant association between coffee drinking and anxiety, depression or psychological symptoms, but reported lower scores on the mental health scale on the SF-36 general health questionnaire. There was no association with tea or caffeine intake. One study \[[@pone.0144405.ref114]\] found no association between dietary zinc intake and depression.

### Impact on other conditions {#sec039}

There is limited evidence regarding the impact of diet on other outcomes. One study reported intake of fruits and vegetables may reduce long-term risk of weight gain in middle-aged women \[[@pone.0144405.ref115]\]. Another study in women reported that weight gain was inversely associated with the intake of high-fibre, wholegrain foods but positively related to the intake of refined-grain foods \[[@pone.0144405.ref116]\]. Higher coffee and caffeine intake was also associated with a significantly lower incidence of Parkinson's Disease \[[@pone.0144405.ref117]\].

The impact of tobacco {#sec040}
---------------------

Summary data, including study location, duration, period of follow-up, effect sizes, and quality scores for tobacco is reported in [Table 3](#pone.0144405.t003){ref-type="table"}.

### Healthy ageing/quality-of-life/well-being {#sec041}

There is consistent evidence demonstrating a detrimental association between smoking and healthy ageing, quality of life or well-being outcomes. One study \[[@pone.0144405.ref030]\] showed that not smoking was related to a favourable older life; another \[[@pone.0144405.ref118]\] found that never-smokers lived longer than heavy smokers, and their extra years were of better quality. Health-related quality of life deteriorated with an increase in daily cigarettes smoked in a dose-dependent manner. The third \[[@pone.0144405.ref119]\] suggests that 'ever smoking' is associated with overall survival and a borderline association with exceptional survival (i.e. free of a set of major diseases and impairments).

### Disability/frailty {#sec042}

There is consistent evidence demonstrating the dose-response relationship between smoking and impaired mobility. One study \[[@pone.0144405.ref120]\] suggests that a history of smoking, especially heavy smoking, with or without quitting, is associated with an earlier onset, and more rapid development, of mobility problems during the transition from middle age to old age. Another \[[@pone.0144405.ref037]\] showed a consistent adverse dose-response relationship between smoking and ill-health (i.e. disability, impaired mobility, health care utilisation, self-reported health).

There is inconsistent evidence demonstrating associations between smoking and low energy fractures. One \[[@pone.0144405.ref121]\] showed that among women, smokers had a higher risk for vertebral fractures than non-smokers. Among men, smokers had a greater risk for low energy fractures, vertebral fractures, proximal humerus fractures, and hip fractures. Other papers showed no association between smoking and wrist fractures \[[@pone.0144405.ref040]\] or osteoporotic fractures \[[@pone.0144405.ref122]\]. One study \[[@pone.0144405.ref043],[@pone.0144405.ref123]\] found a positive association between smoking and risk of osteoarthritis. No studies we found assessed frailty.

### Dementia & cognition {#sec043}

There is strong evidence demonstrating the association between smoking in mid-life and dementia, or cognitive decline, in later life. The association between smoking and specific types of dementia is less clear. In most studies smoking was strongly associated with dementia \[[@pone.0144405.ref026],[@pone.0144405.ref124]--[@pone.0144405.ref127]\], subsequent risk of hospitalisation with dementia \[[@pone.0144405.ref026]\], and with being diagnosed with dementia \[[@pone.0144405.ref128]\]. Two studies \[[@pone.0144405.ref052],[@pone.0144405.ref129]\] showed an association between smoking and cognition. One \[[@pone.0144405.ref051]\] showed that smoking in middle age is associated with memory deficit and decline in reasoning abilities; long-term ex-smokers (compared to current smokers and recent ex-smokers) are less likely to have cognitive deficits in memory, vocabulary, and verbal fluency. Another \[[@pone.0144405.ref130]\] reported greater decline in memory function, cognitive flexibility, and cognitive function among smokers. The declines in all cognitive domains were larger with increasing number of pack-years smoked. Only one study \[[@pone.0144405.ref131]\] found that smoking at baseline was not associated with change in cognitive decline whilst another \[[@pone.0144405.ref132]\] looking at dementia death failed to demonstrate an association with smoking. In another study \[[@pone.0144405.ref133]\], mid-life smoking was associated with an increased rate of progression of vascular brain injury, global and hippocampal atrophy.

### Overall mortality {#sec044}

There is strong evidence demonstrating a dose-response relationship between smoking in mid-life and total mortality. Compared to never smokers, smokers are at increased risk of mortality. Five studies \[[@pone.0144405.ref118],[@pone.0144405.ref134]--[@pone.0144405.ref137]\] showed that current smokers showed the highest risks of total mortality with a dose-response relationship with increasing number of cigarettes smoked. One \[[@pone.0144405.ref135]\] showed that men smoking persistently were most at risk, while those who persisted in quitting had no increased risk of death compared with non-smokers. Another \[[@pone.0144405.ref138]\] concluded that smokers across the entire range of pulmonary function may increase their expectation of lifespan by giving up smoking. Finally, one study \[[@pone.0144405.ref139]\] showed that compared to current smokers, never smokers, long-term quitters and new quitters had a decreased risk of all-cause mortality; the same association was observed for never smokers and long-term quitters for other non-lung cancer mortality. Compared to those who maintained their smoking habit, individuals that reduced or quit smoking had a decreased risk of all-cause mortality \[[@pone.0144405.ref140]\].

### Cardiovascular outcomes {#sec045}

Smoking or having smoked is consistently associated with increased risk of cardiovascular mortality and CVD. Six studies provide evidence of a strong association between smoking and cardiovascular mortality \[[@pone.0144405.ref137],[@pone.0144405.ref139]--[@pone.0144405.ref143]\], with current smokers being more likely to die from cardiovascular events compared to non-smokers. Only one study didn't support this association \[[@pone.0144405.ref144]\]. Other studies provide evidence of a strong association between smoking and cardiovascular events and outcomes \[[@pone.0144405.ref059],[@pone.0144405.ref134],[@pone.0144405.ref145]--[@pone.0144405.ref153]\]. The highest risks for both CHD events and stroke were seen in heavy current smokers \[[@pone.0144405.ref134]\]. Smoking also increases the risk of CHD in men of all APOE genotypes but particularly in men carrying the e4 allele \[[@pone.0144405.ref145],[@pone.0144405.ref154]\]. Only one showed no association between smoking and CHD \[[@pone.0144405.ref146]\]; all other studies have shown an association between smoking and stroke \[[@pone.0144405.ref059],[@pone.0144405.ref146],[@pone.0144405.ref147]\] and myocardial infarction \[[@pone.0144405.ref148]\].

### Diabetes/metabolic syndrome {#sec046}

Cigarette smoking is an independent and modifiable risk factor for type 2 diabetes; however, the evidence for insulin sensitivity and metabolic syndrome is not sufficient to conclude. Three studies \[[@pone.0144405.ref068],[@pone.0144405.ref155],[@pone.0144405.ref156]\], demonstrated cigarette smoking is an independent and modifiable risk factor for type 2 diabetes and one did not \[[@pone.0144405.ref157]\]. One \[[@pone.0144405.ref068]\] reported the risk of diabetes in those who switched from smoking cigarettes to pipe or cigars remained equal to the risk in continuing cigarette smokers. Other studies showed that smoking is a risk factor for type 2 diabetes independently of BMI and physical activity \[[@pone.0144405.ref155]\]; however another \[[@pone.0144405.ref157]\] found that smoking was associated with the metabolic syndrome but not diabetes. Finally, one study \[[@pone.0144405.ref066]\] found no significant association with insulin sensitivity and smoking in men.

There is some evidence to suggest that the use of smokeless tobacco in mid-life is related to type 2 diabetes \[[@pone.0144405.ref158]\]. The use of smokeless tobacco was associated with low insulin response but not low insulin sensitivity.

### Impact on cancer {#sec047}

Evidence showed a consistent association between smoking and cancer with a dose-response effect. The dose-response and exposure association seems to depend on the type of cancer considered \[[@pone.0144405.ref134],[@pone.0144405.ref159],[@pone.0144405.ref160]\]; current cigarette smokers showed the highest risk of total cancer with a strong dose-response effect. In a study \[[@pone.0144405.ref161]\] looking specifically at pancreatic cancer in women, pancreatic cancer incidence was greater in current smokers, with the risk increasing with the number of cigarettes smoked. One \[[@pone.0144405.ref159]\] showed that smoking was significantly associated with colorectal cancer in men and not significantly in women. Current cigarette smoking is associated with an elevated lung cancer risk approximately 10- to 20-fold higher for squamous cell and small cell carcinoma and 2- to 3-fold higher for adenocarcinoma in both men and women \[[@pone.0144405.ref160]\]. Another \[[@pone.0144405.ref162]\] confirmed the strong association between smoking and cancer, and cancer-related mortality. Compared to current smokers, never smokers, long-term quitters and new quitters also had a decreased risk of lung cancer mortality \[[@pone.0144405.ref139]\].

### Impact on other conditions {#sec048}

One study reported that being a smoker was significantly associated with weight loss \[[@pone.0144405.ref163]\].

No studies were identified which assessed the impact on mental health.

The impact of alcohol {#sec049}
---------------------

Summary data, including study location, duration, period of follow-up, effect sizes, and quality scores for alcohol is reported in [Table 3](#pone.0144405.t003){ref-type="table"}.

### Disability/frailty {#sec050}

Two studies reported higher odds for ill-health and osteoporotic fractures among alcohol drinkers compared to non-drinkers, while one study found no link between alcohol intake and wrist fractures \[[@pone.0144405.ref040]\]. Conversely, the risk for any incident osteoporotic fracture was reported to be higher among male alcohol users compared to male teetotallers \[[@pone.0144405.ref122]\]. A large study \[[@pone.0144405.ref037]\] showed that respondents with a past drinking problem had the highest odds for ill-health in terms of ADL dependence, difficulty climbing stairs, difficulty walking, poor health, and hospitalization. No studies we found assessed frailty.

### Dementia & cognition {#sec051}

There is consistent evidence demonstrating an association between alcohol abstinence and/or heavy drinking and cognitive impairment \[[@pone.0144405.ref052],[@pone.0144405.ref164]--[@pone.0144405.ref166]\]. Compared to moderate alcohol intake, alcohol abstinence was associated with a higher risk of poor executive function and poor memory \[[@pone.0144405.ref052]\]. One study reported no association with impairment cognition or dementia \[[@pone.0144405.ref046]\].

### Overall mortality {#sec052}

Evidence was mixed for associations between alcohol consumption and all-cause mortality. One study \[[@pone.0144405.ref119]\] reported excessive alcohol consumption was associated with overall and exceptional survival at age 85 years. One \[[@pone.0144405.ref167]\] showed that alcohol intake was associated with a higher risk for all-cause mortality. Another \[[@pone.0144405.ref168]\] showed that excessive mortality was significantly associated with heavy drinking among men diagnosed with cancer and cardiovascular disease in this time period. One reported no association between ethanol consumption and chronic obstructive pulmonary disease mortality \[[@pone.0144405.ref169]\].

### Cardiovascular outcomes {#sec053}

The evidence regarding alcohol use and cardiovascular outcomes is inconsistent. Three studies \[[@pone.0144405.ref167],[@pone.0144405.ref170],[@pone.0144405.ref171]\] showed a significant association between alcohol intake and cardiovascular outcomes. Regular drinkers had a significantly lower risk of major CHD events, CHD deaths, and CVD deaths in comparison with occasional drinkers after full adjustment for lifestyle characteristics and pre-existing disease \[[@pone.0144405.ref170]\]. Heavy drinkers had a higher risk of both major CHD and stroke compared to occasional drinkers \[[@pone.0144405.ref167],[@pone.0144405.ref171]\]. No significant associations were observed between alcohol intake and cardiovascular outcomes in three studies (e.g., disease development, death) \[[@pone.0144405.ref046],[@pone.0144405.ref093],[@pone.0144405.ref144]\].

### Diabetes/metabolic syndrome {#sec054}

Findings were consistent with respect to the influence of alcohol intake on diabetes/metabolic syndrome. Three studies \[[@pone.0144405.ref172]--[@pone.0144405.ref174]\] found significant positive associations between alcohol intake levels and diabetes/metabolic syndrome, while one study \[[@pone.0144405.ref046]\] did not find an association.

### Impact on cancer {#sec055}

There is mixed evidence demonstrating the absence of an association between alcohol intake and cancer. Three studies \[[@pone.0144405.ref046],[@pone.0144405.ref175],[@pone.0144405.ref176]\] did not find significant associations between alcohol intake and incident and fatal pancreatic cancer; cancer in general; and colorectal cancer, respectively. In contrast, another study \[[@pone.0144405.ref159]\] showed a significantly higher risk for colorectal cancer among men who drink alcohol compared to non-drinkers. That study \[[@pone.0144405.ref159]\] reported that approximately half of the reported colorectal cancer cases may be preventable by tobacco and alcohol controls in middle-aged Japanese men; however the portion attributable to alcohol is not known.

### Impact on mental health {#sec056}

Evidence on the impact on mental health is limited. One study \[[@pone.0144405.ref070]\] of women indicated that past alcohol drinkers had lower anxiety than non-drinkers.

No studies were identified which assessed the impact on healthy ageing, quality of life, well-being.

The impact of weight change/weight cycling {#sec057}
------------------------------------------

Summary data, including study location, duration, period of follow-up, effect sizes, and quality scores for weight change/weight cycling is reported in [Table 3](#pone.0144405.t003){ref-type="table"}.

### Disability/frailty {#sec058}

There is limited evidence that weight loss of more than 10% of max body weight in mid-life is related to hip fractures \[[@pone.0144405.ref177]\]. The impact was statistically significant for those aged 50--64 and 65--74 years who were weight cycling (as defined by study authors) in mid-life.

### Dementia and cognition {#sec059}

There is limited evidence to suggest that weight change in mid-life is related to dementia \[[@pone.0144405.ref178]\]. Those in the highest two quartiles of weight change had a significantly higher risk of dementia, independent of the direction of weight change.

### Overall mortality {#sec060}

One study reported no association between weight cycling in mid-life and mortality \[[@pone.0144405.ref179]\].

### Diabetes/metabolic syndrome {#sec061}

One study \[[@pone.0144405.ref180]\] reported longitudinal associations between weight change/weight cycling and diabetes. The impact was not significant for weight change or weight cycling but overall weight status was more important in those who were overweight or obese at increased risk of diabetes.

No studies were identified which assessed the impact on healthy ageing, quality of life, well-being, cardiovascular outcomes, cancer or mental health.

The impact of leisure, cognitive activities and social network {#sec062}
--------------------------------------------------------------

Summary data, including study location, duration, period of follow-up, effect sizes, and quality scores from leisure, cognitive activities and social network studies is reported in [Table 3](#pone.0144405.t003){ref-type="table"}.

### Healthy ageing/quality-of-life/well-being {#sec063}

There is little evidence to determine if leisure and cognitive activities, and an individual's social network in mid-life are related to successful aging. One study \[[@pone.0144405.ref030]\] reported longitudinal associations between leisure, cognitive activities, social network and successful aging in both men and women. While there was a beneficial association these were non-significant. No studies we found assessed quality of life or well-being.

### Dementia and cognition {#sec064}

There is some evidence that leisure and cognitive activities, and an individual's social network in mid-life is related to a lower risk of cognitive decline in later life. One study \[[@pone.0144405.ref049]\] reported an association between diversity and intensity of participation in intellectual, physical and passive activities and lower risk of AD. Three studies \[[@pone.0144405.ref181]--[@pone.0144405.ref183]\] reported longitudinal associations between leisure, cognitive activities, social network and dementia or cognitive impairment. All studies reported a beneficial association between mid-life factors and dementia or cognitive decline in later life; however in one study the associations were non-significant for some activities including social, organisational and physical activities \[[@pone.0144405.ref183]\]. There is limited evidence for a prospective association between mid-life mental distress and dementia \[[@pone.0144405.ref184]\].

### Cardiovascular outcomes {#sec065}

We found no evidence on the association between leisure activity, cognitive activity or social networks in mid-life and late life cardiovascular outcomes apart from one study which found no correlation with reduced hypertension in women \[[@pone.0144405.ref151]\].

No studies were identified which assessed the impact of these behaviours on disability, frailty, overall mortality, diabetes, cancer or mental health.

Combined behavioural risks {#sec066}
--------------------------

Summary data, including study location, duration, period of follow-up, effect size, and quality scores from combined lifestyle studies are reported in [Table 3](#pone.0144405.t003){ref-type="table"}.

### Dementia & cognition {#sec067}

There is limited evidence to suggest that combined healthy behaviours in mid-life is related to less risk of dementia in later life. Three studies \[[@pone.0144405.ref046],[@pone.0144405.ref185],[@pone.0144405.ref186]\] reported longitudinal associations between healthy behaviours and dementia or cognitive impairment; one study \[[@pone.0144405.ref185]\] reported that modifiable psychosocial and behavioural factors have protective effects on cognition and another \[[@pone.0144405.ref164]\] reported that higher levels of consumption was associated with higher risk of cognitive impairment, in particular that binge drinking was found to be an independent risk factor for cognitive impairment; however in one study the associations were non-significant\[[@pone.0144405.ref046]\].

### Overall mortality {#sec068}

There is evidence to suggest that reducing unhealthy behaviours or adopting a healthier lifestyle in mid-life is related to reduced death. Two cohort studies \[[@pone.0144405.ref046],[@pone.0144405.ref187]\] reported a significant negative association between number of unhealthy behaviours and mortality.

### Cardiovascular outcomes {#sec069}

There is inconsistent evidence that reducing unhealthy behaviours or adopting healthier behaviours in mid-life is related to reduced CVD. One study reported a significant negative association between number of unhealthy behaviours and CVD \[[@pone.0144405.ref187]\] while the other \[[@pone.0144405.ref046]\] reported no association. Importantly the combined behaviours in these two studies vary.

### Diabetes/metabolic syndrome {#sec070}

There is limited evidence that association exists between reducing unhealthy combined lifestyle behaviours in mid-life are related to diabetes. One study examined the impact of combined lifestyle on diabetes; while there was a negative correlation this was non-significant \[[@pone.0144405.ref046]\].

### Cancer {#sec071}

There is no evidence that association exists between reducing unhealthy combined lifestyle behaviours and cancer. One study examined the impact of combined lifestyle on cancer and there was no correlation \[[@pone.0144405.ref046]\].

No studies were identified which assessed the impact on healthy ageing, quality of life, well-being, disability, frailty or mental health.

Disadvantaged and minority groups {#sec072}
---------------------------------

For this review 'disadvantaged and minority groups' includes (but is not limited to) people of low socioeconomic status; ethnic minority groups; LGBT community groups; travellers; and other groups with protected characteristics under the equality and diversity legislation. One study examined associations between mid-life smoking and reported no difference in the risk of developing dementia by gender or ethnicity \[[@pone.0144405.ref026]\] or the risk of cardiovascular disease, total CHD or myocardial infarction by gender \[[@pone.0144405.ref143]\]. One \[[@pone.0144405.ref028]\] reported less risk of myocardial infarction in women participating in leisure time sports, however this result was based on a small sample size. High alcohol intake in lower SES groups is related to poorer cognitive performance\[[@pone.0144405.ref029]\]. No association between alcohol consumption and cognitive performance was found in those in intermediate or high socioeconomic groups. There is limited evidence and where evidence is available this is generally weak. Most of these groups also have substantially lower life expectancy than the general population, with fewer surviving into age groups of the highest risk.

Discussion {#sec073}
==========

This review provides an overview of the available evidence from high quality observational studies reporting on the association between specific behavioural risk factors, in mid-life, and successful ageing and the primary prevention or delay of DDF and non-communicable chronic conditions. The conclusions of individual cohort studies are consistent with existing knowledge and best practice for a range of specific non communicable disorders (for example, reducing alcohol and tobacco consumption, and increasing physical activity and intake of fruit and vegetables).

The findings that consistently emerge as being of societal importance in their range of potential impact are physical activity, which is beneficial, and smoking is consistently found to be associated with DDF and non-communicable chronic conditions. Other factors for which the evidence base is not as strong are diet, alcohol, weight change and social/leisure activities.

For Physical Activity there was consistent evidence within the 45 studies identified that mid-life PA is associated with better late life DDF and NCC outcomes. Only two studies specifically focused on physical inactivity. This finding is in alignment with previous research that suggests regular PA can reduce the risk of chronic disease and improve one's health and well-being whereas a lack of physical activity leads to poorer health \[[@pone.0144405.ref188]--[@pone.0144405.ref190]\].

The review found a wealth of evidence from longitudinal cohort studies relating to the association between mid-life smoking and poorer DDF and NCC outcomes. The impact of tobacco is well known as previous research demonstrates that tobacco consumption is an important risk factor for CVD, cancer and hypertension, and is a major cause of premature mortality \[[@pone.0144405.ref191],[@pone.0144405.ref192]\]. Whilst smoking cessation is associated with weight gain and a subsequent increase in risk of diabetes, the long-term benefits of giving up smoking outweigh the adverse effects of early weight gain.

There is some consistent evidence from 48 studies that healthy diets have beneficial effects on DDF and NCC outcomes and higher consumption of saturated fat or processed and red meat is associated with poorer ageing, DDF and NCC outcomes. Previous research has also demonstrated a strong relationship between diet, dietary patterns or nutrient intakes, and prevention and management of chronic diseases \[[@pone.0144405.ref193],[@pone.0144405.ref194]\] including diabetes \[[@pone.0144405.ref195]\] and CVD \[[@pone.0144405.ref196]\].

Evidence from 24 studies specific to mid-life alcohol consumption was mixed and inconsistent with smaller effect sizes than for smoking and physical activity. Some studies reported negative outcomes (e.g. for dementia, mortality and cancer) and some more positive outcomes (e.g. for ageing and mental health). Previous research suggests that alcohol is a significant cause of mortality, morbidity and social problems, both in developed and in developing countries \[[@pone.0144405.ref197]\], causing an estimated 4% of the global disease burden including chronic diseases and certain cancers, as well as poor health in general \[[@pone.0144405.ref198]--[@pone.0144405.ref200]\].

Four studies were included that reported an association between weight change patterns in mid-life and later outcomes, including increased risk of hip fracture, mortality, diabetes and dementia. For issues specific to weight change or weight cycling it is known that being overweight increases the risks for many chronic medical conditions, including diabetes, heart disease, hypertension and stroke \[[@pone.0144405.ref201]\]. Modest reductions in weight can lead to important health benefits \[[@pone.0144405.ref067],[@pone.0144405.ref202]\], while fatigue and unintentional weight loss can affect an individual's physical, psychological, social and cognitive functioning \[[@pone.0144405.ref203],[@pone.0144405.ref204]\]. Combinations of lifestyle behaviours were also protective factors in relation to cognitive function, diabetes, vascular disease, cancer, dementia and mortality.

There is little evidence on the impact of leisure, cognitive activities and social network and combined lifestyles. Studies that focused on disadvantaged groups have tended to be few in number and of lower quality indicating that this is a neglected research area.

Limitations of the Evidence, Gaps {#sec074}
=================================

Limited evidence was found specifically relating to mid-life behaviours for leisure activities including cognitive activities and social networks, weight change and weight cycling and smokeless tobacco. While many diet-related studies were found they covered a broad range of diets and dietary components. There were some diets or dietary components for which studies specifically pertaining to mid-life was not found.

For the following exposures only one study was identified:

-   Evidence of the impact of PA on stroke \[[@pone.0144405.ref061]\]; CHD \[[@pone.0144405.ref056],[@pone.0144405.ref205]\]; CVD \[[@pone.0144405.ref053]\]; bone mineral density \[[@pone.0144405.ref042]\]; insulin sensitivity \[[@pone.0144405.ref066]\]; and risk of anxiety and/or depression \[[@pone.0144405.ref069]\].

-   Evidence of the impact of diet, consumption of dietary calcium, vitamin A, vitamin C, zinc and flavonoids on CVD mortality \[[@pone.0144405.ref083]\], overall mortality \[[@pone.0144405.ref084]\], and psychological distress \[[@pone.0144405.ref206]\].

-   Evidence on the impact of tobacco on total cancer \[[@pone.0144405.ref134]\]; pancreatic cancer \[[@pone.0144405.ref175]\]; colorectal cancer \[[@pone.0144405.ref159]\]; risks of lung cancer \[[@pone.0144405.ref207]\] and lung cancer mortality \[[@pone.0144405.ref139]\]; cancer related mortality \[[@pone.0144405.ref162]\]; quality of life \[[@pone.0144405.ref118]\]; psychological distress \[[@pone.0144405.ref037]\]; impaired mobility \[[@pone.0144405.ref120]\]; risk of chronic kidney condition \[[@pone.0144405.ref208]\]; and smokeless tobacco on type 2 diabetes \[[@pone.0144405.ref209]\]; weight and weight maintenance \[[@pone.0144405.ref210]\].

-   Evidence on the impact of alcohol on major coronary heart disease and stroke \[[@pone.0144405.ref167]\]; ADL dependence, difficulty climbing stairs, difficulty walking, poor health, and hospitalization \[[@pone.0144405.ref037]\]; wrist fractures \[[@pone.0144405.ref040]\]; dementia \[[@pone.0144405.ref046]\]; COPD mortality \[[@pone.0144405.ref169]\]; incident and fatal pancreatic cancer \[[@pone.0144405.ref175],[@pone.0144405.ref211]\]; cancer in general\[[@pone.0144405.ref046]\]; and colorectal cancer \[[@pone.0144405.ref176]\].

No studies were found which reported: physical inactivity and healthy ageing/quality of life/well-being, dementia, diabetes/metabolic syndrome, cancer or mental health; the relationship between alcohol consumption and healthy ageing/quality of life/well-being; weight change/weight cycling with healthy ageing/quality of life/well-being, CVD outcomes, cancer or mental health; impacts on disability/frailty, diabetes/metabolic syndrome, cancer, overall mortality, mental health or other chronic diseases; or the impact of combined lifestyle behaviours and healthy ageing/quality of life/well-being, disability/frailty, mental health or other chronic diseases; studies of behaviour related to hearing or vision. The challenge in assessing the impact of these exposures is a pronounced lack of data.

While no included studies reported relationship between mid-life physical activity and dementia, a recent meta-analysis \[[@pone.0144405.ref212]\] of prospective studies was published subsequently to the completion of the review and reported a fixed effects risk ratio of 0.61 (95% CI 0.52--0.73) indicating an overall reduction in risk of Alzheimer's disease in physically active older adults.

There is also substantial heterogeneity in the measurement of exposures and outcomes included in this review making precise comparisons between studies problematic. While the review only includes longitudinal observational studies, which can show an association between mid-life risk factors and later life outcomes, associations from this type of study are not necessarily causal.

There was a paucity of data relating to disadvantaged groups covered by the equality and diversity legislation. While we found evidence assessing the risks of developing: dementia by gender or ethnicity \[[@pone.0144405.ref026]\]; CVD, total CHD or MI by gender \[[@pone.0144405.ref143]\], and in women \[[@pone.0144405.ref028]\] only, also alcohol intake in lower SES groups \[[@pone.0144405.ref029]\]. No longitudinal data was found relevant to other groups covered by the equality and diversity legislation such as LGBT groups or travellers. The absence of large-scale, high-quality research in these communities is problematic as there is a need for a more detailed and accurate picture of the disparities these communities face. Disadvantaged groups are significantly more likely to experience pervasive discrimination \[[@pone.0144405.ref213]\] and without clear evidence, the challenges faced are exacerbated. Whilst there have been some gains for visibility and equality for these communities, many disparities remain, particularly for women and the poorest (most vulnerable) in our society. Poorer health and well-being will persist, if high rates of discrimination are allowed to continue resulting in the experience of deeper inequality. Solutions to the disparities addressed above must focus both on reducing discrimination in general and improving conditions of living. Given that discrimination has a cumulative negative effect on health, there are plausible reasons for anticipating differences for disadvantaged groups or settings. These are the important considerations that should be made to ensure that inequities are reduced. There is therefore very little information about how mid-life behaviours in disadvantaged communities' impact on population-level health outcomes in later life. More data is needed to understand how the behavioural risks are differentially modulated in these disadvantaged groups; with the aim of designing interventions that are fit for purpose.

Limitations of the Review {#sec075}
=========================

The remit of this rapid review was specifically to identify mid-life behavioural risk factors for DDF outcomes and common NCCs in later life. Determinants of DDF over the whole life course were not included. Pragmatically, due to the wide scope of the review, the large amount of literature covering behavioural risk factors and the outcomes of interest, and the timescales for the review, the searches were focused on studies with mid-life-related terms in the title, abstract or related MeSH indexing to identify those studies that specifically aimed to report on mid-life exposure. The implication is that cohort studies that have followed individuals from mid- to late life and reported associations of interest without specifying mid-life terms in the title or abstract were not identified by the searches. This might explain some of the gaps in evidence and further work is on-going to address this limitation.

Although we conducted a rapid systematic review it is unlikely that our overall conclusions would vary greatly had a systematic review been conducted over a longer period of time \[[@pone.0144405.ref199]\]. Another strength is that unlike other rapid reviews a quality assessment of the included studies was undertaken reducing the limitations associated with the evidence synthesis process and results \[[@pone.0144405.ref200]\].

Also, only OECD countries are included, which may impact on the implications of findings within the broader global health context. However, few studies from non-OECD countries were found in the searches.

Conclusion {#sec076}
==========

The long-term impact of beneficial behavioural factors in middle to older age adults was greater chance of successful ageing and the primary prevention or delay of disability, dementia, frailty, and non-communicable chronic conditions. The exposures and health behaviours in mid-life identified in this review are important considerations both in identifying possible differential mechanisms for action (in order to reduce ill-health in the population) and the design of interventions to improve healthy behaviours.
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